Clinical applicability and interpretation of calcium–mediated parathyroid hormone suppression phenotyping in post-transplant hyperparathyroidism
Kidney International · 2026-06 · 109 (6) · 1325-1326
DOI: 10.1016/j.kint.2026.02.026 ↗Kurz gefasst
Leserbrief in der Zeitschrift Kidney International, 2026-06. Verfasst von Huanxue Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Shengjing Hospital of China Medical University, Shenyang, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, Shengjing Hospital of China Medical University, Shenyang, China.
- Dalian Rehabilitation Recuperation Center of PLA Joint Logistics Support Force, Dalian, China.
- Department of Infectious Diseases, Shengjing Hospital of China Medical University, Shenyang, China. Electronic address: liy20@sj-hospital.org.
Zitieren
APA
Chen, H., Wang, W., & Li, Y. (2026). Clinical applicability and interpretation of calcium–mediated parathyroid hormone suppression phenotyping in post-transplant hyperparathyroidism. Kidney International, 109(6), 1325-1326. https://doi.org/10.1016/j.kint.2026.02.026
Vancouver
Chen H, Wang W, Li Y. Clinical applicability and interpretation of calcium–mediated parathyroid hormone suppression phenotyping in post-transplant hyperparathyroidism. Kidney International. 2026;109(6):1325-1326. doi:10.1016/j.kint.2026.02.026
BibTeX
@article{Chen2026,
author = {Chen, Huanxue and Wang, Weiyi and Li, Yao},
title = {Clinical applicability and interpretation of calcium–mediated parathyroid hormone suppression phenotyping in post-transplant hyperparathyroidism},
journal = {Kidney International},
year = {2026},
volume = {109},
number = {6},
pages = {1325--1326},
doi = {10.1016/j.kint.2026.02.026}
}
EUVIMED